P3 Health Partners Inc. Cash Flow Statement
PIII|4 years of annual SEC 10-K data (FY2021-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
P3 Health Partners Inc. used $110M in operating cash flow and negative free cash flow of $112M in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income | -$135.8M | -$270.1M | -$146.4M | -$42.0M |
| Depreciation & Amortization | $86.1M | $87.3M | $1.6M | $399.2K |
| Operating Cash Flow | -$110.1M | -$126.0M | -$51.1M | -$28.3M |
| Capital Expenditures | $1.8M | $2.2M | $3.3M | $1.5M |
| Free Cash Flow | -$112.0M | -$128.3M | -$54.4M | -$29.7M |
| FCF Margin | -7.5% | -12.2% | -9.4% | -20.4% |